From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Doctors and front-line workers are watching closely as HIV rates increase significantly in Alberta.An annual Alberta Health ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...

Leerink has upgraded Gilead Sciences (NASDAQ:GILD) to outperform, citing the growth outlook for its PrEP treatment ...

The Executive Director of UNAIDS Winnie Byanyima is calling for accelerated global solidarity to strengthen Madagascar's response to HIV, including preventing new HIV infections and expanding access ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

Kidney stones cause a range of symptoms as they pass from the kidneys out of the body through the urethra. Learn about pain, ...

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

Gilead Sciences and Merck presented Phase 2 results showing 94.2% viral suppression in HIV patients treated with islatravir and lenacapavir. Both weekly and daily treatments achieved comparable ...